The Journal of Immunology, Vol 158, Issue 1 112-119, Copyright © 1997 by American Association of Immunologists

ARTICLES

Phenotypic and functional characterization of long-lived NK cell lines of different maturational status obtained from mouse fetal liver

M Manoussaka, A Georgiou, B Rossiter, S Shrestha, JA Toomey, PV Sivakumar, M Bennett, V Kumar and CG Brooks
Department of Immunology, Medical School, University of Newcastle, Newcastle upon Tyne, United Kingdom.

Culture of day 14 mouse fetal liver (FL) cells in high dose IL-2, together with appropriate combinations of IL-4 and PMA, resulted in the generation of cell lines, termed FL-A lines, that were phenotypically and functionally indistinguishable from cultured adult splenic NK cell populations with the single important exception that no Ly49-expressing cells were present. By contrast, when FL cells were cultured in low- dose IL-2 alone, a second population of slow-growing NK-like cells, termed FL-B cells, emerged. These cells expressed the NK markers asialoGM1, 10A7, 2B4, and Fc gammaRII/III but differed from FL-A and splenic NK cells in expressing IL-2R alpha and stem cell factor receptor (SCFR) but no B220. Most lines derived in this manner had minimal or no cytolytic activity and only very low levels of NK1.1. However, they could secrete substantial quantities of several lymphokines including IL-3, granulocyte-macrophage (GM)-CSF, TNF-alpha, and, most surprisingly, IL-2. A minority of FL-B lines, typified by line 903, displayed marked cytolytic activity, moderate levels of NK1.1, reduced production of IL-2, and the capacity for accelerated growth in high-dose IL-2. FL-B lines generally expressed mRNA for CD3gamma but not for other CD3 chains, whereas FL-A and fetal thymic (FT) NK lines often expressed mRNA for all four CD3 chains. Despite many similarities to pro-T cells, FL-B cells showed no capacity to differentiate into mature T cells. Taken together, our results suggest that NK lines of different maturity can be obtained from fetal liver, with FL-B lines being the most immature, FL-A lines the most mature, and lines such as FL-B 903 representing an intermediate state of differentiation.

This article has been cited by other articles:

				S. Iizuka, T. Kaifu, A. Nakamura, M. Obinata, and T. Takai Establishment and Functional Characterization of Novel Natural Killer Cell Lines Derived from a Temperature-Sensitive SV40 Large T Antigen Transgenic Mouse J. Biochem., August 1, 2006; 140(2): 255 - 265. [Abstract] [Full Text] [PDF]

				J. A. Toomey, F. Gays, D. Foster, and C. G. Brooks Cytokine requirements for the growth and development of mouse NK cells in vitro J. Leukoc. Biol., August 1, 2003; 74(2): 233 - 242. [Abstract] [Full Text] [PDF]

				N. Toyama-Sorimachi, Y. Taguchi, H. Yagita, F. Kitamura, A. Kawasaki, S. Koyasu, and H. Karasuyama Mouse CD94 Participates in Qa-1-Mediated Self Recognition by NK Cells and Delivers Inhibitory Signals Independent of Ly-49 J. Immunol., March 15, 2001; 166(6): 3771 - 3779. [Abstract] [Full Text] [PDF]

				F. Gays, K. P. Fraser, J. A. Toomey, A. G. Diamond, M. M. Millrain, P. J. Dyson, and C. G. Brooks Functional Analysis of the Molecular Factors Controlling Qa1-Mediated Protection of Target Cells from NK Lysis J. Immunol., February 1, 2001; 166(3): 1601 - 1610. [Abstract] [Full Text] [PDF]

				J. A. Toomey, M. Salcedo, L. A. Cotterill, M. M. Millrain, Z. Chrzanowska-Lightowlers, J. Lawry, K. Fraser, F. Gays, J. H. Robinson, S. Shrestha, et al. Stochastic Acquisition of Qa1 Receptors During the Development of Fetal NK Cells In Vitro Accounts in Part But Not in Whole for the Ability of These Cells to Distinguish Between Class I-Sufficient and Class I-Deficient Targets J. Immunol., September 15, 1999; 163(6): 3176 - 3184. [Abstract] [Full Text] [PDF]

				J. Lindberg, A. Martin-Fontecha, and P. Hoglund Natural killing of MHC class I– lymphoblasts by NK cells from long-term bone marrow culture requires effector cell expression of Ly49 receptors Int. Immunol., August 1, 1999; 11(8): 1239 - 1246. [Abstract] [Full Text] [PDF]

				P. V. Sivakumar, A. Gunturi, M. Salcedo, J. D. Schatzle, W. C. Lai, Z. Kurepa, L. Pitcher, M. S. Seaman, F. A. Lemonnier, M. Bennett, et al. Cutting Edge: Expression of Functional CD94/NKG2A Inhibitory Receptors on Fetal NK1.1+Ly-49- Cells: A Possible Mechanism of Tolerance During NK Cell Development J. Immunol., June 15, 1999; 162(12): 6976 - 6980. [Abstract] [Full Text] [PDF]

				B. Wang, N. Wang, C. E. Whitehurst, J. She, J. Chen, and C. Terhorst T Lymphocyte Development in the Absence of CD3{epsilon} or CD3{gamma}{delta}{epsilon}{zeta} J. Immunol., January 1, 1999; 162(1): 88 - 94. [Abstract] [Full Text] [PDF]

				M. S. Manoussaka, R. J. Smith, V. Conlin, J. A. Toomey, and C. G. Brooks Fetal Mouse NK Cell Clones Are Deficient in Ly49 Expression, Share a Common Broad Lytic Specificity, and Undergo Continuous and Extensive Diversification In Vitro J. Immunol., March 1, 1998; 160(5): 2197 - 2206. [Abstract] [Full Text] [PDF]

				J. R. Carlyle, A. M. Michie, S. K. Cho, and J. C. Zuniga-Pflucker Natural Killer Cell Development and Function Precede {alpha}{beta} T Cell Differentiation in Mouse Fetal Thymic Ontogeny J. Immunol., January 15, 1998; 160(2): 744 - 753. [Abstract] [Full Text] [PDF]

				J. R. Carlyle, A. M. Michie, C. Furlonger, T. Nakano, M. J. Lenardo, C. J. Paige, and J. C. Zuniga-Pflucker Identification of a Novel Developmental Stage Marking Lineage Commitment of Progenitor Thymocytes J. Exp. Med., July 21, 1997; 186(2): 173 - 182. [Abstract] [Full Text] [PDF]